Experts aren’t leads. The relationships that change clinical practice are built before you need them, and your own network is the best data you will ever have. This guide shows how to organise it, prioritise it and grow it, with AI as a guide, not a base. These are lessons from my own path, shared to compare notes. Take what’s useful, adapt it to your market, and tell me what you’d do differently.
Everything below goes deeper. Jump to what’s useful to you and skip the rest.
Who do we engage, and why? Who owns each relationship? Does any of it change clinical practice? Three shifts make these questions harder, and more important, every year.
It sits across societies, committees, guideline groups and digital channels, not only with a few senior names.
The same expert hears from global, regional and local teams, often in the same month.
Organising what you know, preparing for meetings and learning from them no longer needs a large team, if your own data feeds it.
Built across eight markets with no brand presence, no network and no history. They apply just as well to a mature team rethinking its approach.
Define what needs to change in practice and which evidence gaps stand in the way. The right experts follow from that, not from a database of famous names.
TryWrite one sentence per priority: "Clinicians need to know ___ to change ___."Experts are not leads to be captured. Trust is earned over time by giving before asking: relevant data, a genuine question, their perspective taken seriously, a follow-up that shows you listened. The colder the contact, the more specific your reason to reach out has to be.
TryBefore your next request, list what you have given this person in the last year.The person who shapes practice is often a society working-group member, a committee chair or the colleague everyone calls for advice, not always the most senior professor.
TryAsk three field colleagues: "Who do clinicians call when they're unsure?"When several teams contact the same expert without coordination, credibility suffers. Agree one owner, and let others contribute through that person.
TryPull last quarter's contacts across teams and count the duplicates.Clear rules on fair-market value, scientific balance and separation from promotion make engagement faster, because teams stop second-guessing every interaction.
TryTurn your top five compliance questions into a one-page decision guide.Meeting counts tell you little. Insights gathered, evidence gaps closed and changes in practice tell you whether engagement is working.
TryReplace one activity KPI with an outcome KPI next quarter.Tap a card to see what actually holds up.
A cycle, not a project. It starts with people, not software. Select a step to see what to do, and where AI helps.
A new market, a new therapy area, a launch. Databases give you names; they don't give you a way in. This is the sequence that worked across eight markets, and became a model others adopted.
Visit, ask what is hard in their daily practice, and say little. Your first credibility comes from understanding their problem, not from your slides.
In many systems the KOL isn't the decision-maker. Technical committees, procurement boards, pharmacy and nursing leads decide what reaches patients. Know both maps.
Small, hands-on sessions where specialists test the science themselves persuade more than any presentation. Let them find the value.
National congresses and society meetings already have the audience. Workshops held alongside them cost less and reach more than standalone events.
One respected clinician who introduces you is worth fifty cold emails. Discovery tools help you choose whom to meet; introductions do the rest.
Write down what worked in market one: the sequence, the materials, the people. It becomes the template for the next market, and the next team.
Generic AI knows what's published. It doesn't know who answers your calls, who changed their practice after your workshop, or who the whole ward asks for advice. That knowledge is yours. Feed it in, and AI becomes useful.
The more of your own knowledge you put in, the higher on this ladder AI is useful. With no data of yours, all it can do is step 3, and that's the weakest.
Starting from zero? Discovery moves first, but only to decide whom to meet. Introductions, congresses and societies do the rest. Once you have a network, the order flips back.
ID, Institution, Specialty, Society / committee roles, Main clinical interests, How we met, Last interaction (date + topic), What they care about, Influence on practice (1–5), Openness to exchange (1–5), Relationship owner, Consent / data basis, Notes
Rate an expert, society or committee on five criteria. The scorer suggests a depth of engagement. Use it to make prioritisation explicit and discussable, not to replace judgement.
Weights: scientific relevance 30%, influence on practice 25%, evidence-gap fit 20%, reach 10%, openness to scientific exchange 15%. Adjust them to your strategy; what matters is that the team agrees on them.
Every mapping tool measures how influential an expert is. None of them measures the relationship. Think of one expert you work with and answer four questions honestly.
Your relationship status and the next move will appear here.
How to open, by temperature. The rule underneath: ask for a perspective, never a favour, and let them offer more.
Open with something specific to them: their paper, their talk, a question their work raised for you.
Ask for their view on one clinical question. Nothing else.
Never a generic introduction, a product, or a meeting request in the first message.
Open with what you did with their last input. Closing the loop is the strongest signal you listened.
Ask for a reaction to something concrete: data, a draft, a plan.
Never let the only contact be when you need something.
Open with the real problem, early, before decisions are made.
Ask for honest disagreement. If they never push back, it isn't as strong as you think.
Never overuse it, or route every team's request through them.
A simple ownership model removes most duplication. Adapt the levels to your organisation; the point is that everyone can see it.
| Relationship | Global | Regional | Local / affiliate |
|---|---|---|---|
| International society leadership | Owns | Contributes | Informed |
| Global guideline authors | Owns | Contributes | Contributes |
| Regional experts and congresses | Informed | Owns | Contributes |
| National societies and committees | Informed | Contributes | Owns |
| Practising specialists and digital voices | Informed | Informed | Owns |
Categorise first, create second, discover last. Each prompt keeps AI grounded in your own data and sources. Use anonymised information, and only tools your company has approved.
You don't need to drop activity counts. Pair each with a measure that shows whether the activity mattered.
Many headline figures in this space (“9x faster shortlisting”, “up to 200% more experts”) come from single-client case studies. They may well be true. Ask five questions before they go into a business case:
From building a network of more than 100 health creators across the Americas, 15 of whom became collaborators, and from designing an AI-guided health platform. Tick them off as you go.
Six statements. Answer honestly; it takes a minute.
Start with one therapy area or one market. Prove the approach, then scale it.